Eva M. Rodriguez-Medina
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Gut microbiome signatures associated with depression and obesity.
Journal: mSystems
Published: January 30, 2026
Are conventional antidepressants enough? The gut microbiome and nanocarrier-based delivery systems as future prospects for depression treatment.
Journal: Neuroscience and biobehavioral reviews
Published: June 27, 2025
Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime.
Journal: Pharmacological reviews
Published: January 30, 2024
Functional Heterogeneity of Mouse and Human Brain OPCs: Relevance for Preclinical Studies in Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: May 07, 2020
A comprehensive profiling of sulfatides in myelin from mouse brain using liquid chromatography coupled to high-resolution accurate tandem mass spectrometry.
Journal: Analytica chimica acta
Published: September 14, 2016
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 14, 2015
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
Journal: PloS one
Published: September 04, 2013
ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin-1 on newborn rat and mouse OPCs via FGFR1.
Journal: Glia
Published: August 12, 2013
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
Journal: Cellular and molecular life sciences : CMLS
Published: October 15, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026